S Motaouakkil, B Charra, A Hachimi, A Benslama. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh： See more » Acinetobacter Infections/drug therapyAcinetobacter Infections/microbiologyAcinetobacter Infections/therapyAcinetobacter baumannii/drug effectsAcinetobacter baumannii/isolation & purificationAdultAgedAnti-Bacterial Agents/administration & dosageAnti-Bacterial Agents/therapeutic useColistin/administration & dosageColistin/therapeutic useCombined Modality TherapyCross Infection/drug therapyCross Infection/microbiologyCross Infection/therapyDrug Resistance, Multiple, BacterialDrug Therapy, CombinationFemaleHumansMaleMiddle AgedPneumonia, Bacterial/drug therapyPneumonia, Bacterial/microbiologyPneumonia, Bacterial/therapyRespiration, ArtificialRifampin/administration & dosageRifampin/therapeutic use
Substances： See more » Anti-Bacterial AgentsRifampinColistin
Year: 2006 PMID： 16488103 DOI： 10.1016/j.annfar.2006.01.006
Source DB: PubMed Journal: Ann Fr Anesth Reanim ISSN： 0750-7658